Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

KBU2046

Copy Product Info
🥰Excellent
Catalog No. T15646Cas No. 1143863-69-7

KBU2046 is an orally administered compound that inhibits cell motility and invasion, effectively suppressing cancer metastasis and extending lifespan. This compound uniquely targets and binds to chaperone heterocomplexes, selectively modifying the interaction of client proteins involved in motility regulation, while avoiding the characteristics typical of classical HSP90 inhibitors.

KBU2046

KBU2046

Copy Product Info
🥰Excellent
Purity: 99.89%
Catalog No. T15646Cas No. 1143863-69-7
KBU2046 is an orally administered compound that inhibits cell motility and invasion, effectively suppressing cancer metastasis and extending lifespan. This compound uniquely targets and binds to chaperone heterocomplexes, selectively modifying the interaction of client proteins involved in motility regulation, while avoiding the characteristics typical of classical HSP90 inhibitors.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$29In StockIn Stock
5 mg$48In StockIn Stock
10 mg$68In StockIn Stock
25 mg$143In StockIn Stock
50 mg$223In StockIn Stock
100 mg$338In StockIn Stock
200 mg$473In StockIn Stock
1 mL x 10 mM (in DMSO)$48In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.89%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

KBU2046 AI Summary
KBU2046 exhibits inhibitory activity against human recombinant aromatase with an IC50 of 33,000.0 nM, as measured using 7-methoxy-trifluoromethylcoumarin in a fluorescent assay. Furthermore, it has an IC50 ratio of 2.0 when comparing its effects on human MCF7 cells to human recombinant aromatase..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
KBU2046 is an orally administered compound that inhibits cell motility and invasion, effectively suppressing cancer metastasis and extending lifespan. This compound uniquely targets and binds to chaperone heterocomplexes, selectively modifying the interaction of client proteins involved in motility regulation, while avoiding the characteristics typical of classical HSP90 inhibitors.
Chemical Properties
Molecular Weight242.24
FormulaC15H11FO2
Cas No.1143863-69-7
SmilesFc1ccc(cc1)C1COc2ccccc2C1=O
Relative Density.1.31g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 45 mg/mL (185.77 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM4.1281 mL20.6407 mL41.2814 mL206.4069 mL
5 mM0.8256 mL4.1281 mL8.2563 mL41.2814 mL
10 mM0.4128 mL2.0641 mL4.1281 mL20.6407 mL
20 mM0.2064 mL1.0320 mL2.0641 mL10.3203 mL
50 mM0.0826 mL0.4128 mL0.8256 mL4.1281 mL
100 mM0.0413 mL0.2064 mL0.4128 mL2.0641 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy KBU2046 | purchase KBU2046 | KBU2046 cost | order KBU2046 | KBU2046 chemical structure | KBU2046 formula | KBU2046 molecular weight